Global Infectious Disease In-vitro Diagnostic Market Research Report 2025(Status and Outlook)
Description
Report Overview
Infectious Disease In-vitro Diagnostics (IVD) refer to medical tests performed on samples such as blood, urine, or tissue to detect infections caused by bacteria, viruses, fungi, or parasites. These tests play a crucial role in diagnosing infectious diseases accurately and quickly, enabling healthcare providers to initiate appropriate treatment promptly. Infectious Disease IVDs encompass a wide range of tests, including immunoassays, molecular diagnostics, and microbiology culture tests, providing valuable information for patient management and public health surveillance.
The market for Infectious Disease IVD is experiencing significant growth due to several key market trends and drivers. One of the primary drivers is the increasing prevalence of infectious diseases worldwide, driven by factors such as globalization, urbanization, and antimicrobial resistance. Additionally, technological advancements in diagnostic techniques, such as the development of rapid molecular tests and point-of-care devices, are driving market growth by improving the speed and accuracy of infectious disease diagnosis. Furthermore, the growing demand for personalized medicine and the rising awareness about the importance of early disease detection are fueling the adoption of Infectious Disease IVDs. At the same time, the COVID-19 pandemic has further highlighted the critical role of diagnostic testing in managing infectious diseases, leading to a surge in demand for IVD products.
The global Infectious Disease In-vitro Diagnostic market size was estimated at USD 58.18 million in 2024 and is projected to reach USD 79.01 million by 2033, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Infectious Disease In-vitro Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease In-vitro Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease In-vitro Diagnostic market in any manner.
Global Infectious Disease In-vitro Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies
Inc.
Hologic
Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories
Inc.
Market Segmentation (by Type)
Immunoassay
Molecular Diagnostics
Microbiology
Others
Market Segmentation (by Application)
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease In-vitro Diagnostic Market
Overview of the regional outlook of the Infectious Disease In-vitro Diagnostic Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease In-vitro Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease In-vitro Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Infectious Disease In-vitro Diagnostics (IVD) refer to medical tests performed on samples such as blood, urine, or tissue to detect infections caused by bacteria, viruses, fungi, or parasites. These tests play a crucial role in diagnosing infectious diseases accurately and quickly, enabling healthcare providers to initiate appropriate treatment promptly. Infectious Disease IVDs encompass a wide range of tests, including immunoassays, molecular diagnostics, and microbiology culture tests, providing valuable information for patient management and public health surveillance.
The market for Infectious Disease IVD is experiencing significant growth due to several key market trends and drivers. One of the primary drivers is the increasing prevalence of infectious diseases worldwide, driven by factors such as globalization, urbanization, and antimicrobial resistance. Additionally, technological advancements in diagnostic techniques, such as the development of rapid molecular tests and point-of-care devices, are driving market growth by improving the speed and accuracy of infectious disease diagnosis. Furthermore, the growing demand for personalized medicine and the rising awareness about the importance of early disease detection are fueling the adoption of Infectious Disease IVDs. At the same time, the COVID-19 pandemic has further highlighted the critical role of diagnostic testing in managing infectious diseases, leading to a surge in demand for IVD products.
The global Infectious Disease In-vitro Diagnostic market size was estimated at USD 58.18 million in 2024 and is projected to reach USD 79.01 million by 2033, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Infectious Disease In-vitro Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc. In terms of regional markets, the report details the market space and development potential of each market segment in North America, Europe, Asia Pacific, South America, the Middle East and Africa, as well as the competitive landscape of major players, etc
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Infectious Disease In-vitro Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Infectious Disease In-vitro Diagnostic market in any manner.
Global Infectious Disease In-vitro Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies
Inc.
Hologic
Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories
Inc.
Market Segmentation (by Type)
Immunoassay
Molecular Diagnostics
Microbiology
Others
Market Segmentation (by Application)
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease In-vitro Diagnostic Market
Overview of the regional outlook of the Infectious Disease In-vitro Diagnostic Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease In-vitro Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease In-vitro Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
178 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Infectious Disease In-vitro Diagnostic
- 1.2 Key Market Segments
- 1.2.1 Infectious Disease In-vitro Diagnostic Segment by Type
- 1.2.2 Infectious Disease In-vitro Diagnostic Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Infectious Disease In-vitro Diagnostic Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Infectious Disease In-vitro Diagnostic Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Infectious Disease In-vitro Diagnostic Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Infectious Disease In-vitro Diagnostic Product Life Cycle
- 3.3 Global Infectious Disease In-vitro Diagnostic Sales by Manufacturers (2020-2025)
- 3.4 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Infectious Disease In-vitro Diagnostic Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers Infectious Disease In-vitro Diagnostic Manufacturing Sites, Area Served, Product Type
- 3.8 Infectious Disease In-vitro Diagnostic Market Competitive Situation and Trends
- 3.8.1 Infectious Disease In-vitro Diagnostic Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Infectious Disease In-vitro Diagnostic Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Infectious Disease In-vitro Diagnostic Industry Chain Analysis
- 4.1 Infectious Disease In-vitro Diagnostic Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Infectious Disease In-vitro Diagnostic Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Infectious Disease In-vitro Diagnostic Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 Global Trade Frictions and Their Impacts to Infectious Disease In-vitro Diagnostic Market
- 5.7 ESG Ratings of Leading Companies
- 6 Infectious Disease In-vitro Diagnostic Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2020-2025)
- 6.3 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2020-2025)
- 6.4 Global Infectious Disease In-vitro Diagnostic Price by Type (2020-2025)
- 7 Infectious Disease In-vitro Diagnostic Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Infectious Disease In-vitro Diagnostic Market Sales by Application (2020-2025)
- 7.3 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) by Application (2020-2025)
- 7.4 Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
- 8 Infectious Disease In-vitro Diagnostic Market Sales by Region
- 8.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
- 8.1.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
- 8.1.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region
- 8.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region
- 8.2.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region
- 8.2.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Infectious Disease In-vitro Diagnostic Sales by Country
- 8.3.2 North America Infectious Disease In-vitro Diagnostic Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Infectious Disease In-vitro Diagnostic Sales by Country
- 8.4.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Infectious Disease In-vitro Diagnostic Sales by Region
- 8.5.2 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Infectious Disease In-vitro Diagnostic Sales by Country
- 8.6.2 South America Infectious Disease In-vitro Diagnostic Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Infectious Disease In-vitro Diagnostic Sales by Region
- 8.7.2 Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Infectious Disease In-vitro Diagnostic Market Production by Region
- 9.1 Global Production of Infectious Disease In-vitro Diagnostic by Region(2020-2025)
- 9.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2020-2025)
- 9.3 Global Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Infectious Disease In-vitro Diagnostic Production
- 9.4.1 North America Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
- 9.4.2 North America Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Infectious Disease In-vitro Diagnostic Production
- 9.5.1 Europe Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
- 9.5.2 Europe Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Infectious Disease In-vitro Diagnostic Production (2020-2025)
- 9.6.1 Japan Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
- 9.6.2 Japan Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Infectious Disease In-vitro Diagnostic Production (2020-2025)
- 9.7.1 China Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
- 9.7.2 China Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 BD
- 10.1.1 BD Basic Information
- 10.1.2 BD Infectious Disease In-vitro Diagnostic Product Overview
- 10.1.3 BD Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.1.4 BD Business Overview
- 10.1.5 BD SWOT Analysis
- 10.1.6 BD Recent Developments
- 10.2 BioMérieux SA
- 10.2.1 BioMérieux SA Basic Information
- 10.2.2 BioMérieux SA Infectious Disease In-vitro Diagnostic Product Overview
- 10.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.2.4 BioMérieux SA Business Overview
- 10.2.5 BioMérieux SA SWOT Analysis
- 10.2.6 BioMérieux SA Recent Developments
- 10.3 Abbott
- 10.3.1 Abbott Basic Information
- 10.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Overview
- 10.3.3 Abbott Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.3.4 Abbott Business Overview
- 10.3.5 Abbott SWOT Analysis
- 10.3.6 Abbott Recent Developments
- 10.4 Quidel Corporation
- 10.4.1 Quidel Corporation Basic Information
- 10.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Overview
- 10.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.4.4 Quidel Corporation Business Overview
- 10.4.5 Quidel Corporation Recent Developments
- 10.5 OraSure Technologies
- 10.5.1 OraSure Technologies Basic Information
- 10.5.2 OraSure Technologies Infectious Disease In-vitro Diagnostic Product Overview
- 10.5.3 OraSure Technologies Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.5.4 OraSure Technologies Business Overview
- 10.5.5 OraSure Technologies Recent Developments
- 10.6 Inc.
- 10.6.1 Inc. Basic Information
- 10.6.2 Inc. Infectious Disease In-vitro Diagnostic Product Overview
- 10.6.3 Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.6.4 Inc. Business Overview
- 10.6.5 Inc. Recent Developments
- 10.7 Hologic
- 10.7.1 Hologic Basic Information
- 10.7.2 Hologic Infectious Disease In-vitro Diagnostic Product Overview
- 10.7.3 Hologic Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.7.4 Hologic Business Overview
- 10.7.5 Hologic Recent Developments
- 10.8 Inc. (Gen Probe)
- 10.8.1 Inc. (Gen Probe) Basic Information
- 10.8.2 Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Overview
- 10.8.3 Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.8.4 Inc. (Gen Probe) Business Overview
- 10.8.5 Inc. (Gen Probe) Recent Developments
- 10.9 Danaher
- 10.9.1 Danaher Basic Information
- 10.9.2 Danaher Infectious Disease In-vitro Diagnostic Product Overview
- 10.9.3 Danaher Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.9.4 Danaher Business Overview
- 10.9.5 Danaher Recent Developments
- 10.10 QIAGEN
- 10.10.1 QIAGEN Basic Information
- 10.10.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Overview
- 10.10.3 QIAGEN Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.10.4 QIAGEN Business Overview
- 10.10.5 QIAGEN Recent Developments
- 10.11 Roche
- 10.11.1 Roche Basic Information
- 10.11.2 Roche Infectious Disease In-vitro Diagnostic Product Overview
- 10.11.3 Roche Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.11.4 Roche Business Overview
- 10.11.5 Roche Recent Developments
- 10.12 Siemens Healthineers AG
- 10.12.1 Siemens Healthineers AG Basic Information
- 10.12.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Overview
- 10.12.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.12.4 Siemens Healthineers AG Business Overview
- 10.12.5 Siemens Healthineers AG Recent Developments
- 10.13 Bio-Rad Laboratories
- 10.13.1 Bio-Rad Laboratories Basic Information
- 10.13.2 Bio-Rad Laboratories Infectious Disease In-vitro Diagnostic Product Overview
- 10.13.3 Bio-Rad Laboratories Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.13.4 Bio-Rad Laboratories Business Overview
- 10.13.5 Bio-Rad Laboratories Recent Developments
- 10.14 Inc.
- 10.14.1 Inc. Basic Information
- 10.14.2 Inc. Infectious Disease In-vitro Diagnostic Product Overview
- 10.14.3 Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
- 10.14.4 Inc. Business Overview
- 10.14.5 Inc. Recent Developments
- 11 Infectious Disease In-vitro Diagnostic Market Forecast by Region
- 11.1 Global Infectious Disease In-vitro Diagnostic Market Size Forecast
- 11.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
- 11.2.3 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size Forecast by Region
- 11.2.4 South America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease In-vitro Diagnostic by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Infectious Disease In-vitro Diagnostic Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Infectious Disease In-vitro Diagnostic by Type (2026-2033)
- 12.1.2 Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Infectious Disease In-vitro Diagnostic by Type (2026-2033)
- 12.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Application (2026-2033)
- 12.2.1 Global Infectious Disease In-vitro Diagnostic Sales (K Units) Forecast by Application
- 12.2.2 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
